Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction

Heart Rhythm

Volumn 4, Issue 8, 2007, Pages 1072-1080

  Hu, Dan ^a,b   Viskin, Sami ^c   Oliva, Antonio ^a,d   Carrier, Tabitha ^a   Cordeiro, Jonathan M ^a   Barajas Martinez, Hector ^a,e   Wu, Yuesheng ^a   Burashnikov, Elena ^a   Sicouri, Serge ^a   Brugada, Ramon ^a   Rosso, Rafael ^d   Guerchicoff, Alejandra ^a   Pollevick, Guido D ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Arrhythmia; Fibrillation; Ischemia; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

ADENOSINE; FLECAINIDE; GENE PRODUCT; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNQ1; SODIUM CHANNEL; SODIUM CHANNEL SCN1B; SODIUM CHANNEL SCN5A; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ALLELE; ARRHYTHMOGENESIS; ARTICLE; BRUGADA SYNDROME; CLINICAL ARTICLE; COHORT ANALYSIS; EXTRASYSTOLE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC CONSERVATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HETEROZYGOSITY; HUMAN; HUMAN CELL; LONG QT SYNDROME; MALE; MISSENSE MUTATION; MUTANT; PATCH CLAMP; PRIORITY JOURNAL; ST SEGMENT; STEADY STATE; WHOLE CELL; WILD TYPE;

ACTION POTENTIALS; ADULT; AGED; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUSCLE PROTEINS; MUTATION, MISSENSE; MYOCARDIAL INFARCTION; PATCH-CLAMP TECHNIQUES; SODIUM CHANNELS; TACHYCARDIA, VENTRICULAR; TRANSFECTION; VENTRICULAR FIBRILLATION;

EID: 34547408462     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.03.040     Document Type: Article

References (33)

1. Solomon S.D., Zelenkofske S., McMurray J.J., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., White H., Van de W.F., Pieper K., Califf R.M., and Pfeffer M.A. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352 (2005) 2581-2588
2. Dekker L.R., Bezzina C.R., Henriques J.P., Tanck M.W., Koch K.T., Alings M.W., Arnold A.E., de Boer M.J., Gorgels A.P., Michels H.R., Verkerk A., Verheugt F.W., Zijlstra F., and Wilde A.A. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 114 (2006) 1140-1145
3. Catterall W.A. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev 72 (1992) S15-S48
4. Roden D.M. Human genomics and its impact on arrhythmias. Trends Cardiovasc Med 14 (2004) 112-116
5. Antzelevitch C. Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. Heart Rhythm 1 (2004) 42C-56C
6. Dumaine R., Towbin J.A., Brugada P., Vatta M., Nesterenko D.V., Nesterenko V.V., Brugada J., Brugada R., and Antzelevitch C. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85 (1999) 803-809
7. Brugada R. Use of intravenous antiarrhythmics to identify concealed Brugada syndrome. Curr Control Trials Cardiovasc Med 1 (2000) 45-47
8. Viskin S., Rosso R., Rogowski O., Belhassen B., Levitas A., Wagshal A., Katz A., Fourey D., Zeltser D., Oliva A., Pollevick G.D., Antzelevitch C., and Rozovski U. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J 27 (2006) 469-475
9. Kaab S., and Schulze-Bahr E. Susceptibility genes and modifiers for cardiac arrhythmias. Cardiovasc Res 67 (2005) 397-413
10. Ackerman M.J., Tester D.J., Jones G.S., Will M.L., Burrow C.R., and Curran M.E. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc 78 (2003) 1479-1487
11. Lukas A., and Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: role of the transient outward current. Circulation 88 (1993) 2903-2915
12. Lukas A., and Antzelevitch C. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res 32 (1996) 593-603
13. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 100 (1999) 1660-1666
14. Yan G.X., Joshi A., Guo D., Hlaing T., Martin J., Xu X., and Kowey P.R. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 110 (2004) 1036-1041
15. Antzelevitch C., Brugada P., Brugada J., Brugada R., Nademanee K., and Towbin J.A. Clinical Approaches to Tachyarrhythmias. The Brugada Syndrome (1999), Blackwell Futura Publishing Co, Armonk, NY 1-99
16. Noda T., Shimizu W., Taguchi A., Satomi K., Suyama K., Kurita T., Aihara N., and Kamakura S. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetylcholine and/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol 40 (2002) 1841-1847
17. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O'Brien R.E., Schultze-Bahr E., Keating M.T., Towbin J.A., and Wang Q. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
18. Schulze-Bahr E., Eckardt L., Breithardt G., Seidl K., Wichter T., Wolpert C., Borggrefe M., and Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 21 (2003) 651-652
19. Smits J.P., Eckardt L., Probst V., Bezzina C.R., Schott J.J., Remme C.A., Haverkamp W., Breithardt G., Escande D., Schulze-Bahr E., LeMarec H., and Wilde A.A. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 40 (2002) 350-356
20. Roden D.M., and Viswanathan P.C. Genetics of acquired long QT syndrome. J Clin Invest 115 (2005) 2025-2032
21. Ye B., Valdivia C.R., Ackerman M.J., and Makielski J.C. A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics 12 (2003) 187-193
22. Viswanathan P.C., Benson D.W., and Balser J.R. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 111 (2003) 341-346
23. Poelzing S., Forleo C., Samodell M., Dudash L., Sorrentino S., Anaclerio M., Troccoli R., Iacoviello M., Romito R., Guida P., Chahine M., Pitzalis M., and Deschenes I. SCN5A Polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 114 (2006) 368-376
24. Makielski J.C., Ye B., Valdivia C.R., Pagel M.D., Pu J., Tester D.J., and Ackerman M.J. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 93 (2003) 821-828
25. Tan B.H., Valdivia C.R., Rok B.A., Ye B., Ruwaldt K.M., Tester D.J., Ackerman M.J., and Makielski J.C. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2 (2005) 741-747
26. Gilmour Jr. R.F., and Zipes D.P. Different electrophysiological responses of canine endocardium and epicardium to combined hyperkalemia, hypoxia, and acidosis. Circ Res 46 (1980) 814-825
27. Kimura S., Bassett A.L., Kohya T., Kozlovskis P.L., and Myerburg R.J. Simultaneous recording of action potentials from endocardium and epicardium during ischemia in the isolated cat ventricle: relation of temporal electrophysiologic heterogeneities to arrhythmias. Circulation 74 (1986) 401-409
28. Di Diego J.M., and Antzelevitch C. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry?. Circulation 88 (1993) 1177-1189
29. Di Diego J.M., and Antzelevitch C. High [Ca2+]-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry. Circulation 89 (1994) 1839-1850
30. Billman G.E. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation. Eur J Pharmacol 229 (1992) 179-187
31. Liu D.W., Gintant G.A., and Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res 72 (1993) 671-687
32. to and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 271 (1996) H548-H561
33. Di Diego J.M., and Antzelevitch C. Cellular basis for ST-segment changes observed during ischemia. J Electrocardiol 36 Suppl (2003) 1-5